Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height

Xencor

Xencor reported $78.33M in Operating Expenses for its fiscal quarter ending in March of 2023.


Operating Expenses Change
AbbVie ABBV:US USD 9.46B 162M
Alnylam Pharmaceuticals ALNY:US USD 469.1M 54.55M
Amgen AMGN:US USD 4.07B 538M
Arrowhead Research ARWR:US USD 98.1M 6.58M
AstraZeneca AZN:LN USD 8.33B 1.78B
Biogen BIIB:US USD 1.96B 111.2M
Bristol-Myers Squibb BMY:US USD 8.24B 1.22B
Cytokinetics CYTK:US USD 129.09M 99K
GlaxoSmithKline GSK:LN GBP 4.87B 640M
J&J JNJ:US USD 25.48B 5.98B
Karyopharm Therapeutics KPTI:US USD 69.6M 2.15M
MacroGenics MGNX:US USD 62.92M 1.81M
Merck & Co MRK:US USD 10.76B 371M
Novartis NOVN:VX USD 10.35B 700M
Pfizer PFE:US USD 11.5B 7.63B
Regeneron Pharmaceuticals REGN:US USD 2.22B 52.2M
Roche Holding ROG:VX 25.06B 4.31B
Seattle Genetics SGEN:US USD 704.23M 22.08M
Xencor XNCR:US USD 78.33M 14.02M